Meeting Banner
Abstract #2855

Non-invasive imaging of deep venous thrombi by 19F MRI using targeted perfluorcarbon nanoemulsions

Sebastian Temme 1 , Christoph Grapentin 2 , Christine Quast 1 , Christoph Jacoby 1 , Zhaoping Ding 3 , Friederike Mayenfels 4 , Jrgen Schrader 1 , and Ulrich Flgel 1

1 Molecular Cardiology, University of Dsseldorf, Dsseldorf, NRW, Germany, 2 Pharmaceutical Technology and Biopharmacy, University of Freiburg, Freiburg, BW, Germany, 3 Molecular Cardiology, University of Dsseldorf, Dsseldorf, Germany, 4 University of Freiburg, Freiburg, BW, Germany

Detection of deep venous thrombi which are not accessible by ultrasound is still a serious challenge. Therefore a non-invasive technique for unequivocal identification of those thrombi for diagnosis and subsequent monitoring of antithrombotic therapy would be highly desirable. Therefore we applied a novel sterol-based post-insertions technique to generate stable lower case Greek alpha 2-antiplasmin targeted PFC-NE for the rapid, highly specific and unequivocal identification of freshly developed deep venous thrombi, which might have a potential clinical application in detection of rethrombosis or lung thromboembolism. Moreover, we propose that the sterol-based post-insertion technique is a promising platform to equip PFC-NE with different ligands (peptides, antibodies etc.) for in-vivo 19F MRI of specific targets.

This abstract and the presentation materials are available to members only; a login is required.

Join Here